Monitoring a Nuclear Factor-κB Signature of Drug Resistance in Multiple Myeloma

Abstract excerpt

The emergence of acquired drug resistance results from multiple compensatory mechanisms acting to prevent cell death. Simultaneous monitoring of proteins involved in drug resistance is a major challenge for both elucidation of the underlying biology and development of candidate biomarkers for assessment of personalized cancer therapy. Here, we have utilized an integrated analytical platform based on SDS-PAGE...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV/AIDS drug development and treatment
• Share to Multiple Myeloma Research and Treatments
• Share to Ubiquitin and proteasome pathways